Free Trial

Medical Properties Trust, Inc. (NYSE:MPW) Holdings Lifted by Advisors Asset Management Inc.

Medical Properties Trust logo with Finance background

Advisors Asset Management Inc. raised its stake in shares of Medical Properties Trust, Inc. (NYSE:MPW - Free Report) by 16.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,367,257 shares of the real estate investment trust's stock after purchasing an additional 192,955 shares during the period. Advisors Asset Management Inc. owned 0.23% of Medical Properties Trust worth $7,998,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of MPW. Future Financial Wealth Managment LLC acquired a new position in shares of Medical Properties Trust during the 3rd quarter valued at $29,000. Versant Capital Management Inc boosted its position in shares of Medical Properties Trust by 435.0% in the second quarter. Versant Capital Management Inc now owns 7,972 shares of the real estate investment trust's stock worth $34,000 after buying an additional 6,482 shares during the period. Iron Horse Wealth Management LLC raised its holdings in shares of Medical Properties Trust by 166.7% during the 2nd quarter. Iron Horse Wealth Management LLC now owns 8,000 shares of the real estate investment trust's stock valued at $34,000 after buying an additional 5,000 shares during the period. GAMMA Investing LLC lifted its position in Medical Properties Trust by 107.3% during the 3rd quarter. GAMMA Investing LLC now owns 6,077 shares of the real estate investment trust's stock worth $36,000 after acquiring an additional 3,145 shares in the last quarter. Finally, Gateway Investment Advisers LLC purchased a new position in Medical Properties Trust in the 2nd quarter worth approximately $45,000. Hedge funds and other institutional investors own 71.79% of the company's stock.

Insiders Place Their Bets

In other Medical Properties Trust news, Director Elizabeth N. Pitman bought 8,087 shares of the stock in a transaction that occurred on Wednesday, September 18th. The shares were purchased at an average cost of $6.01 per share, for a total transaction of $48,602.87. Following the transaction, the director now directly owns 76,740 shares in the company, valued at $461,207.40. The trade was a 11.78 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director C Reynolds Thompson III sold 20,530 shares of the business's stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total value of $89,921.40. Following the transaction, the director now owns 54,637 shares of the company's stock, valued at $239,310.06. This trade represents a 27.31 % decrease in their position. The disclosure for this sale can be found here. 1.53% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on MPW shares. Wolfe Research raised shares of Medical Properties Trust to a "hold" rating in a research report on Monday, September 23rd. Colliers Securities upgraded Medical Properties Trust from a "neutral" rating to a "buy" rating and set a $6.50 target price for the company in a research note on Friday, September 13th. Finally, Truist Financial boosted their price target on Medical Properties Trust from $5.00 to $6.00 and gave the stock a "hold" rating in a research note on Friday, September 13th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, Medical Properties Trust has a consensus rating of "Hold" and an average price target of $5.50.

View Our Latest Analysis on Medical Properties Trust

Medical Properties Trust Stock Performance

NYSE MPW traded down $0.02 during trading hours on Thursday, hitting $4.24. The company had a trading volume of 9,408,630 shares, compared to its average volume of 16,722,859. The business has a fifty day simple moving average of $5.10 and a 200-day simple moving average of $4.90. The firm has a market cap of $2.54 billion, a P/E ratio of -1.00, a price-to-earnings-growth ratio of 0.67 and a beta of 1.32. The company has a quick ratio of 2.38, a current ratio of 2.38 and a debt-to-equity ratio of 1.69. Medical Properties Trust, Inc. has a fifty-two week low of $2.92 and a fifty-two week high of $6.55.

About Medical Properties Trust

(Free Report)

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

Featured Stories

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

→ Financial Prophecy (From Porter & Company) (Ad)

Should you invest $1,000 in Medical Properties Trust right now?

Before you consider Medical Properties Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.

While Medical Properties Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines